Skip to content
GinjerNews

BloombergBusiness

Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says

By Sanne Wass

Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.

This story was published by Bloomberg. Read the full article on their site.

Read the full story at bloomberg.com(opens in a new tab)

More Business